NEWARK, CALIFORNIA / ACCESS Newswire / February 25, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) (“Protagonist” or “the Company”) today reported financial results for the fourth quarter and full year ...
LUXEMBOURG, LU / ACCESS Newswire / February 18, 2026 / Ternium S.A. (NYSE:TX) today announced its results for the fourth quarter and full year ended December 31, 2025. The financial and operational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results